PharmaBoardroom

Interview with Luis Ricciardulli, Regional Manager, Nycomed Latin…

The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe…

Interview with José Tombazzi, President, Denver Farma

Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately…

Interview with Helen Allars and John Edington, Managing Director…

The Australian pharmaceutical sector has seen recent innovations through PBS reform and various working groups shaping the future of the industry. Can…

Interview with Dan Brown , Managing Director, Genzyme Australia

What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare &…

Interview with Nicola Roxon, Minister, Department of Health and…

New Government health priorities and policies, highlighting those concerning preventive health. The Rudd Labor Government’s goal in health is to…

Interview with Ian Chalmers, Chief Executive, Medicines Australia

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry…

Interview with Jean-Pierre Salama, CEO, Pharmacor

Pharmacor is one of the newest entities on the Australian pharmaceutical market. Would you please introduce the company to let Pharmaceutical…

Interview with Willem Dekker , Regional Director, Nycomed…

What impact have the PBS reforms had on Nycomed? As most mid size Pharma companies that operate in a setting of mass market prescription medicines,…

Interview with Lloyd Sansom, Emeritus Professor, Australia

Would you please introduce the PBAC and the role it plays in Australia’s pharmaceutical sector? The Pharmaceutical Benefits Advisory Committee…

Interview with Fabian Dwyer, General Manager, IMS Health…

How have your experiences at Quintiles, Astra, Baxter, and Innovex – covering the spectrum from small to large pharma in addition to the service…

Interview with Juliet Seifert , Executive Director, Australian…

Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international…

Interview with Brendan Shaw, Executive Director, Health Policy…

To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents…

Tagged with